Last reviewed · How we verify

The platelet rich plasma（PRP）

Peking University Third Hospital · Phase 3 active Small molecule

The platelet rich plasma（PRP） is a Autologous cell therapy / Regenerative medicine Small molecule drug developed by Peking University Third Hospital. It is currently in Phase 3 development for Osteoarthritis (knee, shoulder, hip), Tendon and ligament injuries, Muscle injuries. Also known as: PRP.

Platelet-rich plasma (PRP) delivers concentrated platelets and growth factors to damaged tissues to promote healing and regeneration.

Platelet-rich plasma (PRP) delivers concentrated platelets and growth factors to damaged tissues to promote healing and regeneration. Used for Osteoarthritis (knee, shoulder, hip), Tendon and ligament injuries, Muscle injuries.

At a glance

Generic nameThe platelet rich plasma（PRP）
Also known asPRP
SponsorPeking University Third Hospital
Drug classAutologous cell therapy / Regenerative medicine
ModalitySmall molecule
Therapeutic areaRegenerative Medicine / Orthopedics / Wound Healing
PhasePhase 3

Mechanism of action

PRP is an autologous blood product obtained by centrifuging a patient's own blood to concentrate platelets, which contain numerous growth factors (PDGF, VEGF, FGF, TGF-β) and cytokines. When injected into damaged tissues, these bioactive molecules stimulate cell proliferation, angiogenesis, and tissue repair. The mechanism relies on paracrine signaling rather than a single molecular target.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about The platelet rich plasma（PRP）

What is The platelet rich plasma（PRP）?

The platelet rich plasma（PRP） is a Autologous cell therapy / Regenerative medicine drug developed by Peking University Third Hospital, indicated for Osteoarthritis (knee, shoulder, hip), Tendon and ligament injuries, Muscle injuries.

How does The platelet rich plasma（PRP） work?

Platelet-rich plasma (PRP) delivers concentrated platelets and growth factors to damaged tissues to promote healing and regeneration.

What is The platelet rich plasma（PRP） used for?

The platelet rich plasma（PRP） is indicated for Osteoarthritis (knee, shoulder, hip), Tendon and ligament injuries, Muscle injuries, Wound healing, Hair loss (androgenetic alopecia).

Who makes The platelet rich plasma（PRP）?

The platelet rich plasma（PRP） is developed by Peking University Third Hospital (see full Peking University Third Hospital pipeline at /company/peking-university-third-hospital).

Is The platelet rich plasma（PRP） also known as anything else?

The platelet rich plasma（PRP） is also known as PRP.

What drug class is The platelet rich plasma（PRP） in?

The platelet rich plasma（PRP） belongs to the Autologous cell therapy / Regenerative medicine class. See all Autologous cell therapy / Regenerative medicine drugs at /class/autologous-cell-therapy-regenerative-medicine.

What development phase is The platelet rich plasma（PRP） in?

The platelet rich plasma（PRP） is in Phase 3.

What are the side effects of The platelet rich plasma（PRP）?

Common side effects of The platelet rich plasma（PRP） include Injection site pain or swelling, Temporary increase in inflammation, Infection (rare).

Related